Bayer continues to expand in the US. More than a third of its drug sales are from here.
Bayer’s pharmaceuticals unit on Friday unveiled plans to invest $2.2 billion in a new manufacturing site in New Albany, Ohio, part of a push to boost the business’s US revenue.
Bayer expects to create about 600 high paying jobs in New Albany, with another 1,500 jobs resulting temporarily from construction.
The prescription drug unit of Germany’s Bayer has increased the US share of global revenue to 35% from 20% in 2018 and it aims to double US sales by the end of the decade, said Sebastian Guth, chief operating officer for pharmaceuticals.
Bayer’s prescription drug unit generates 35% of its global revenue from the United States in dollar sales, not in product.
Because Bayer sells its pharmaceuticals for 5x to 10x the cost in the United States as compared to most countries